TY - JOUR
T1 - Uric Acid and Urate in Urolithiasis
T2 - The Innocent Bystander, Instigator, and Perpetrator
AU - Adomako, Emmanuel
AU - Moe, Orson W.
N1 - Funding Information:
Financial support: The authors are supported by the National Institutes of Health ( R01 DK081423 , R01 DK115703 , R01 DK091392 , and DK092461 ), the O'Brien Kidney Research Center ( P30 DK-079328 ), the Charles and Jane Pak Center of Mineral Metabolism, and the Clinical Research Endowed Professor Collaborative Research Support and Innovative Research Program.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/11
Y1 - 2020/11
N2 - Summary: Uric acid is an end product of purine metabolism in human beings. An unusual and still unexplained phenomenon is that higher primates have relatively high uric acid levels in body fluids owing to a combination of absence of degradation and renal retention. The physiologic purpose of high uric acid levels still is enigmatic, but the pathobiologic burden is a variety of crystallopathies owing to the low aqueous solubility of uric acid such as gouty arthritis and acute uric acid nephropathy. In the urinary space, three distinct conditions result from chronic uric acid and/or urate precipitation. The first and most common variety is uric acid urolithiasis. In this condition, urate is a victim of a systemic metabolic disease in which increased acid load to the kidney is coupled with diminished urinary buffer capacity owing to defective ammonium excretion, resulting in titration of urate to its sparingly soluble protonated counterpart, uric acid, and the formation of stones. Uric acid is the innocent bystander of the crime. The second variety is hyperuricosuric calcium urolithiasis, in which uric acid confers lithogenicity via promotion of calcium oxalate precipitation by multiple mechanisms involving soluble, colloidal, and crystalline urate salts. Uric acid is the instigator of the crime. The third and least common condition involves urate as an integral part of the urolith as an ammonium salt driven by high ammonium and high urate concentrations in urine. Here, uric acid is one of the perpetrators of the crime. Both known and postulated pathogenesis of these three types of urolithiasis are reviewed and summarized.
AB - Summary: Uric acid is an end product of purine metabolism in human beings. An unusual and still unexplained phenomenon is that higher primates have relatively high uric acid levels in body fluids owing to a combination of absence of degradation and renal retention. The physiologic purpose of high uric acid levels still is enigmatic, but the pathobiologic burden is a variety of crystallopathies owing to the low aqueous solubility of uric acid such as gouty arthritis and acute uric acid nephropathy. In the urinary space, three distinct conditions result from chronic uric acid and/or urate precipitation. The first and most common variety is uric acid urolithiasis. In this condition, urate is a victim of a systemic metabolic disease in which increased acid load to the kidney is coupled with diminished urinary buffer capacity owing to defective ammonium excretion, resulting in titration of urate to its sparingly soluble protonated counterpart, uric acid, and the formation of stones. Uric acid is the innocent bystander of the crime. The second variety is hyperuricosuric calcium urolithiasis, in which uric acid confers lithogenicity via promotion of calcium oxalate precipitation by multiple mechanisms involving soluble, colloidal, and crystalline urate salts. Uric acid is the instigator of the crime. The third and least common condition involves urate as an integral part of the urolith as an ammonium salt driven by high ammonium and high urate concentrations in urine. Here, uric acid is one of the perpetrators of the crime. Both known and postulated pathogenesis of these three types of urolithiasis are reviewed and summarized.
KW - Kidney stones
KW - ammonium urate
KW - calcium
KW - hyperuricosuric
KW - uric acid urolithiasis
UR - http://www.scopus.com/inward/record.url?scp=85100542005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100542005&partnerID=8YFLogxK
U2 - 10.1016/j.semnephrol.2020.12.003
DO - 10.1016/j.semnephrol.2020.12.003
M3 - Review article
C2 - 33678311
AN - SCOPUS:85100542005
SN - 0270-9295
VL - 40
SP - 564
EP - 573
JO - Seminars in nephrology
JF - Seminars in nephrology
IS - 6
ER -